Cell Reports (May 2014)

Impeded Nedd4-1-Mediated Ras Degradation Underlies Ras-Driven Tumorigenesis

  • Taoling Zeng,
  • Qun Wang,
  • Jieying Fu,
  • Qi Lin,
  • Jing Bi,
  • Weichao Ding,
  • Yikai Qiao,
  • Sheng Zhang,
  • Wenxiu Zhao,
  • Huayue Lin,
  • Meilin Wang,
  • Binfeng Lu,
  • Xianming Deng,
  • Dawang Zhou,
  • Zhenyu Yin,
  • Hong-Rui Wang

DOI
https://doi.org/10.1016/j.celrep.2014.03.045
Journal volume & issue
Vol. 7, no. 3
pp. 871 – 882

Abstract

Read online

RAS genes are among the most frequently mutated proto-oncogenes in cancer. However, how Ras stability is regulated remains largely unknown. Here, we report a regulatory loop involving the E3 ligase Nedd4-1, Ras, and PTEN. We found that Ras signaling stimulates the expression of Nedd4-1, which in turn acts as an E3 ubiquitin ligase that regulates Ras levels. Importantly, Ras activation, either by oncogenic mutations or by epidermal growth factor (EGF) signaling, prevents Nedd4-1-mediated Ras ubiquitination. This leads to Ras-induced Nedd4-1 overexpression, and subsequent degradation of the tumor suppressor PTEN in both human cancer samples and cancer cells. Our study thus unravels the molecular mechanisms underlying the interplay of Ras, Nedd4-1, and PTEN and suggests a basis for the high prevalence of Ras-activating mutations and EGF hypersignaling in cancer.